RPE65 and Atrophy: The metabolic effect-based hypothesis is corroborated by the evidence of a greater improvement in the FST results in the atrophy group suggesting that RPE65 overexpression might drive atrophy development, as highlighted by the German-American cohort of 71 eyes.